Government brings 42 non-scheduled cancer drugs under price control

As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, the release said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news